Ubs Group Ag Helius Medical Technologies, Inc. Transaction History

Ubs Group Ag

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.14 - $0.25 $6,167 - $11,012	-44,051 Reduced 97.55%	1,106 $0
Q1 2023 May 12, 2023	BUY	$0.23 - $0.41 $2,496 - $4,450	10,854 Added 31.64%	45,157 $11,000
Q4 2022 Feb 08, 2023	BUY	$0.22 - $14.5 $1,069 - $70,484	4,861 Added 16.51%	34,303 $10,000
Q3 2022 Nov 10, 2022	BUY	$0.36 - $17.1 $8,924 - $423,891	24,789 Added 532.75%	29,442 $8,000
Q2 2022 Aug 10, 2022	BUY	$1.14 - $3.48 $5,298 - $16,175	4,648 Added 92960.0%	4,653 $5,000
Q1 2022 May 16, 2022	SELL	$3.07 - $5.55 $2,931 - $5,300	-955 Reduced 99.48%	5 $0
Q4 2021 Feb 14, 2022	BUY	$5.12 - $14.5 $808 - $2,291	158 Added 19.7%	960 $5,000
Q3 2021 Nov 15, 2021	BUY	$12.9 - $16.83 $3,999 - $5,217	310 Added 63.01%	802 $11,000
Q2 2021 Aug 13, 2021	SELL	$13.28 - $18.45 $24,076 - $33,449	-1,813 Reduced 78.66%	492 $8,000
Q1 2021 May 12, 2021	BUY	$11.23 - $18.35 $25,885 - $42,296	2,305 New	2,305 $41,000

Ticker HSDT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,197,200
Market Cap $13.8M
Description
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gai...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.